Literature DB >> 23997209

Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study.

Yariv Gerber, Susan A Weston, Cecilia Berardi, Sheila M McNallan, Ruoxiang Jiang, Margaret M Redfield, Véronique L Roger.   

Abstract

Major changes have recently occurred in the epidemiology of myocardial infarction (MI) that could possibly affect outcomes such as heart failure (HF). Data describing trends in HF after MI are scarce and conflicting and do not distinguish between preserved and reduced ejection fraction (EF). We evaluated temporal trends in HF after MI. All residents of Olmsted County, Minnesota (n = 2,596) who had a first-ever MI diagnosed in 1990-2010 and no prior HF were followed-up through 2012. Framingham Heart Study criteria were used to define HF, which was further classified according to EF. Both early-onset (0-7 days after MI) and late-onset (8 days to 5 years after MI) HF were examined. Changes in patient presentation were noted, including fewer ST-segment-elevation MIs, lower Killip class, and more comorbid conditions. Over the 5-year follow-up period, 715 patients developed HF, 475 of whom developed it during the first week. The age- and sex-adjusted risk declined from 1990-1996 to 2004-2010, with hazard ratios of 0.67 (95% confidence interval (CI): 0.54, 0.85) for early-onset HF and 0.63 (95% CI: 0.45, 0.86) for late-onset HF. Further adjustment for patient and MI characteristics yielded hazard ratios of 0.86 (95% CI: 0.66, 1.11) and 0.63 (95% CI: 0.45, 0.88) for early- and late-onset HF, respectively. Declines in early-onset and late-onset HF were observed for HF with reduced EF (<50%) but not for HF with preserved EF, indicating a change in the case mix of HF after MI that requires new prevention strategies.

Entities:  

Keywords:  cardiovascular diseases; community studies; ejection fraction; heart failure; myocardial infarction; population-based studies; secular trends; surveillance

Mesh:

Year:  2013        PMID: 23997209      PMCID: PMC3792728          DOI: 10.1093/aje/kwt109

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  40 in total

1.  Trends in prevalence and outcome of heart failure with preserved ejection fraction.

Authors:  Theophilus E Owan; David O Hodge; Regina M Herges; Steven J Jacobsen; Veronique L Roger; Margaret M Redfield
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

2.  A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.

Authors:  Xu Zhang; Fausto R Loberiza; John P Klein; Mei-Jie Zhang
Journal:  Comput Methods Programs Biomed       Date:  2007-09-11       Impact factor: 5.428

Review 3.  Essential features of a surveillance system to support the prevention and management of heart disease and stroke: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease.

Authors:  David C Goff; Lawrence Brass; Lynne T Braun; Janet B Croft; Judd D Flesch; Francis G R Fowkes; Yuling Hong; Virginia Howard; Sara Huston; Stephen F Jencks; Russell Luepker; Teri Manolio; Christopher O'Donnell; Rose Marie Robertson; Wayne Rosamond; John Rumsfeld; Stephen Sidney; Zhi Jie Zheng
Journal:  Circulation       Date:  2006-12-18       Impact factor: 29.690

Review 4.  Chronic heart failure in the United States: a manifestation of coronary artery disease.

Authors:  M Gheorghiade; R O Bonow
Journal:  Circulation       Date:  1998-01-27       Impact factor: 29.690

5.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

6.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

7.  Systolic and diastolic heart failure in the community.

Authors:  Francesca Bursi; Susan A Weston; Margaret M Redfield; Steven J Jacobsen; Serguei Pakhomov; Vuyisile T Nkomo; Ryan A Meverden; Véronique L Roger
Journal:  JAMA       Date:  2006-11-08       Impact factor: 56.272

8.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Authors:  L Køber; C Torp-Pedersen; J E Carlsen; H Bagger; P Eliasen; K Lyngborg; J Videbaek; D S Cole; L Auclert; N C Pauly
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245

9.  Long-term trends in the incidence of heart failure after myocardial infarction.

Authors:  Raghava S Velagaleti; Michael J Pencina; Joanne M Murabito; Thomas J Wang; Nisha I Parikh; Ralph B D'Agostino; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

10.  Sudden death after myocardial infarction.

Authors:  A Selcuk Adabag; Terry M Therneau; Bernard J Gersh; Susan A Weston; Véronique L Roger
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

View more
  29 in total

1.  Atherosclerotic Burden and Heart Failure After Myocardial Infarction.

Authors:  Yariv Gerber; Susan A Weston; Maurice Enriquez-Sarano; Sheila M Manemann; Alanna M Chamberlain; Ruoxiang Jiang; Véronique L Roger
Journal:  JAMA Cardiol       Date:  2016-05-01       Impact factor: 14.676

2.  Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus.

Authors:  Pooyan Kazemian; Deborah J Wexler; Naomi F Fields; Robert A Parker; Amy Zheng; Rochelle P Walensky
Journal:  Diabetes Technol Ther       Date:  2019-06       Impact factor: 6.118

3.  PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.

Authors:  Arshed A Quyyumi; Alejandro Vasquez; Dean J Kereiakes; Marc Klapholz; Gary L Schaer; Ahmed Abdel-Latif; Stephen Frohwein; Timothy D Henry; Richard A Schatz; Nabil Dib; Catalin Toma; Charles J Davidson; Gregory W Barsness; David M Shavelle; Martin Cohen; Joseph Poole; Thomas Moss; Pamela Hyde; Anna Maria Kanakaraj; Vitaly Druker; Amy Chung; Candice Junge; Robert A Preti; Robin L Smith; David J Mazzo; Andrew Pecora; Douglas W Losordo
Journal:  Circ Res       Date:  2016-11-07       Impact factor: 17.367

4.  Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer.

Authors:  Tal Hasin; Yariv Gerber; Susan A Weston; Ruoxiang Jiang; Jill M Killian; Sheila M Manemann; James R Cerhan; Véronique L Roger
Journal:  J Am Coll Cardiol       Date:  2016-07-19       Impact factor: 24.094

5.  Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.

Authors:  Ramachandran S Vasan; Vanessa Xanthakis; Asya Lyass; Charlotte Andersson; Connie Tsao; Susan Cheng; Jayashri Aragam; Emelia J Benjamin; Martin G Larson
Journal:  JACC Cardiovasc Imaging       Date:  2017-10-05

6.  A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.

Authors:  Yariv Gerber; Susan A Weston; Margaret M Redfield; Alanna M Chamberlain; Sheila M Manemann; Ruoxiang Jiang; Jill M Killian; Véronique L Roger
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

7.  Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective.

Authors:  Yariv Gerber; Susan A Weston; Maurice Enriquez-Sarano; Cecilia Berardi; Alanna M Chamberlain; Sheila M Manemann; Ruoxiang Jiang; Shannon M Dunlay; Véronique L Roger
Journal:  Circ Heart Fail       Date:  2015-12-23       Impact factor: 8.790

8.  Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.

Authors:  Ambarish Pandey; Muthiah Vaduganathan; Sameer Arora; Arman Qamar; Robert J Mentz; Sanjiv J Shah; Patricia P Chang; Stuart D Russell; Wayne D Rosamond; Melissa C Caughey
Journal:  Circulation       Date:  2020-06-03       Impact factor: 29.690

9.  Impact of Race, Ethnicity, and Multimodality Biomarkers on the Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-Ethnic Study of Atherosclerosis).

Authors:  Michael G Silverman; Birju Patel; Ron Blankstein; Joao A C Lima; Roger S Blumenthal; Khurram Nasir; Michael J Blaha
Journal:  Am J Cardiol       Date:  2016-02-17       Impact factor: 2.778

10.  Multimorbidity in heart failure: a community perspective.

Authors:  Alanna M Chamberlain; Jennifer L St Sauver; Yariv Gerber; Sheila M Manemann; Cynthia M Boyd; Shannon M Dunlay; Walter A Rocca; Lila J Finney Rutten; Ruoxiang Jiang; Susan A Weston; Véronique L Roger
Journal:  Am J Med       Date:  2014-09-16       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.